Consultations at Windermere include a detailed cost estimate before you commit to a treatment plan
Novo Nordisk recently presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that oral semaglutide significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD)
Digital care platform : Log in to view your current dose, future shipment schedule, and lab review history (if applicable)
Their AI-powered and human doctor services offer quick, reliable answers and convenient video visits to help manage your treatment effectively
It is important to consider alternative causes of fatigue, including anaemia, thyroid dysfunction, or other concurrent medical conditions, particularly if symptoms are severe or persistent